REGULATION OF GELATINASE PRODUCTION IN METASTATIC RENAL CELL-CARCINOMA BY ORGAN-SPECIFIC FIBROBLASTS

被引:58
|
作者
GOHJI, K
NAKAJIMA, M
FABRA, A
BUCANA, CD
VONESCHENBACH, AC
TSURUO, T
FIDLER, IJ
机构
[1] UNIV TOKYO,INST MOLEC & CELLULAR BIOSCI,BUNKYO KU,TOKYO 113,TOKYO,JAPAN
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT CELL BIOL,HOUSTON,TX 77030
[3] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT UROL,HOUSTON,TX 77030
[4] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030
[5] HOSP DURAN & REYNALS,INST REC ONCOL,DEPT CANC & METASTASI,E-08907 BARCELONA,SPAIN
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1994年 / 85卷 / 02期
关键词
RENAL CELL CARCINOMA; METASTASIS; GELATINASE; FIBROBLAST;
D O I
10.1111/j.1349-7006.1994.tb02076.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have recently established a human renal cell carcinoma KG-2 line that is tumorigenic in the subcutis (ectopic) and kidney (orthotopic) of nude mice but spontaneously metastasizes to the lung only after orthotopic implantation. KG-2 cells growing in the kidney (orthotopic) and lung metastases secreted higher levels of gelatinase than did cells growing in the subcutis (ectopic). We examined whether organ-specific fibroblasts play a role in the regulation of gelatinase production and invasion by renal carcinoma cells. The gelatinase level in the culture supernatants of KG-2 cells was increased by their cultivation with mouse kidney or lung fibroblasts. In contrast, cocultivation of KG-2 cells with mouse skin fibroblasts resulted in a significant reduction of gelatinase activity. Similar results were obtained by culturing KG-2 cells in the media conditioned by the different mouse fibroblasts. We, therefore, investigated effects on KG-2 cells of cytokines and growth factors known to be produced by fibroblasts of various origins. Of ten cytokines and growth factors tested, basic fibroblast growth factor, hepatocyte growth factor, and transforming growth factor-beta(1) (TGF-beta(1)) stimulated gelatinase expression by the cultured KG-2 cells. Parallel immunohistochemical analyses revealed that mouse kidney and lung fibroblasts produced higher levels of TGF-beta(1) than did skin fibroblasts. These results indicate that gelatinase production by KG-2 renal cell carcinoma cells is influenced by the organ microenvironment. Specifically, organ-specific fibroblasts regulate the production of degradative enzymes by KG-2 cells and, hence, profoundly influence their invasive and metastatic capacity.
引用
收藏
页码:152 / 160
页数:9
相关论文
共 50 条
  • [41] Tumor evolution of brain-specific tropism in metastatic renal cell carcinoma
    Elias, Roy
    ONCOLOGIST, 2024, 29 : S7 - S7
  • [42] Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
    Piaseczny, Matthew M.
    Pio, Graciella M.
    Chu, Jenny E.
    Xia, Ying
    Nguyen, Kim
    Goodale, David
    Allan, Alison
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (112):
  • [43] Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Lu, Li-Chun
    Hsu, Chiun
    Shao, Yu-Yun
    Chao, Yee
    Yen, Chia-Jui
    Shih, I-Lun
    Hung, Yi-Ping
    Chang, Chun-Jung
    Shen, Ying-Chun
    Guo, Jhe-Cyuan
    Liu, Tsung-Hao
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    LIVER CANCER, 2019, 8 (06) : 480 - 490
  • [44] A CASE OF SIMULTANEOUS CONTRALATERAL RENAL-CELL CARCINOMA AND URETERAL TRANSITIONAL CELL-CARCINOMA
    ADACHI, Y
    KUBOTA, Y
    IRISAWA, C
    WATANABE, H
    ISHII, N
    SUZUKI, K
    NAKADA, T
    IRISAWA, S
    UROLOGIA INTERNATIONALIS, 1991, 46 (01) : 67 - 69
  • [45] Treatment of metastatic renal cell carcinoma
    Thuret, R.
    Maurin, C.
    Sun, M.
    Perrotte, P.
    Karakiewicz, P. I.
    PROGRES EN UROLOGIE, 2011, 21 (04): : 233 - 244
  • [46] Treatment of metastatic renal cell carcinoma
    Reeves, David J.
    Liu, Chin Y.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 11 - 25
  • [47] Treatment of metastatic renal cell carcinoma
    David J. Reeves
    Chin Y. Liu
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 11 - 25
  • [48] Sunitinib for metastatic renal cell carcinoma
    Mukherji, Deborah
    Larkin, James
    Pickering, Lisa
    FUTURE ONCOLOGY, 2010, 6 (09) : 1377 - 1385
  • [49] Treatment of Metastatic Renal Cell Carcinoma
    Sadeghi, Sarmad
    Quinn, David I.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (06) : 5 - 9
  • [50] Nephrectomy in metastatic renal cell carcinoma
    Steven C. Campbell
    Robert C. Flanigan
    Joseph I. Clark
    Current Treatment Options in Oncology, 2003, 4 (5) : 363 - 372